The platform enables collection of breath samples from the deep lung while eliminating contamination from the mouth, upper airways, and environment.

While the effort could bring new requirements to the reimbursement process, it could also make payments more standardized and ...

The oversubscribed round will support final assay development and manufacturing readiness for an early access program launch.

The study included 3,014 patients evaluated based on high-risk screening, symptomatic presentation, or identification of a mass on imaging.

While the effort could bring new requirements to the reimbursement process, it could also make payments more standardized and predictable.

Last week, readers were most interested in a story about Roche's molecular respiratory panel receiving CE marking.

The FDA clearances address laboratory challenges including staff shortages, limited space, and rising test volumes, the firm said.

NEW YORK – Canadian diagnostics artificial intelligence developer Lunit and South Korean contract research firm CellCarta have formed a strategic collaboration to further accelerate the adoption of ...